Please login to the form below

Not currently logged in
Email:
Password:

Martin Brass

This page shows the latest Martin Brass news and features for those working in and with pharma, biotech and healthcare.

Fishawack acquires Blue Latitude Health

Fishawack acquires Blue Latitude Health

Front row L-R: Martin Brass, Gail Flockhart . The Fishawack Group has added another string to its bow, acquiring creative consultancy Blue Latitude Health.

Latest news

  • Blue Latitude Health expands into the US Blue Latitude Health expands into the US

    Co-founder and managing director at Blue Latitude Health Martin Brass said: “We are very excited to be expanding and opening an office in New York City, where we will be

  • Blue Latitude retains Janssen contract Blue Latitude retains Janssen contract

    Martin Brass (pictured), Blue Latitude co-founder and managing director, added: “We are absolutely thrilled to extend our partnership with Janssen to include their brand teams in the EMEA region and

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 6 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics